Jorge Zerón-Medina

Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer

Laura Mezquita, Édouard Auclin, Roberto Ferrara et al. · JAMA Oncology · 2018 · 951 citations · Full text

Life Sciences, Immunology, Oncology +17

A Polymorphic p53 Response Element in KIT Ligand Influences Cancer Risk and Has Undergone Natural Selection

Jorge Zerón-Medina, Xuting Wang, Emmanouela Repapi et al. · Cell · 2013 · 123 citations · Full text

Medicine, Genetics, Molecular Genetics +15

Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis

M.T. Allende, Jorge Zerón-Medina, Javier Hernández‐Losa et al. · Pancreas · 2017 · 63 citations

Medicine, Oncology, Pathology +17

A Polymorphic Enhancer near GREM1 Influences Bowel Cancer Risk through Differential CDX2 and TCF7L2 Binding

Annabelle Lewis, Luke Freeman-Mills, Elisa de la Calle‐Mustienes et al. · Cell Reports · 2014 · 49 citations · Full text

Medicine, Genetics, Molecular Genetics +17

First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma

Erika Hamilton, Judy S. Wang, Amit M. Oza et al. · Molecular Cancer Therapeutics · 2023 · 27 citations · Full text

Medicine, Oncology, Pharmacology +16